{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:27:57Z","timestamp":1791959277212,"version":"4.3.4"},"reference-count":38,"publisher":"American Association for Cancer Research (AACR)","issue":"12","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Primary testing for human papillomavirus (HPV) in cervical screening requires triage to differentiate women with transient infection from those with persistent infection who require more intensive management given their risk for cervical (pre)cancer. In this study, the clinical performance of a novel methylation marker FAM19A4 for the triage of high-risk (hr)HPV-positive women was evaluated. Using a training-validation set approach, we analyzed a FAM19A4 quantitative methylation-specific PCR (qMSP). The training set comprised hrHPV-positive cervical scrapes of 43 women with cervical intraepithelial neoplasia grade 3 or worse (CIN3+) and 135 women with \u2264CIN1. The validation set comprised hrHPV-positive cervical scrapes of 52 women with CIN2+, including 33 CIN3+, 19 CIN2, and 166 women with \u2264CIN1. The methylation threshold of FAM19A4 qMSP that gave rise to CIN3+ specificity of 70% in the training set was applied in the validation set. This resulted in CIN3+ sensitivity of 75.8% [95% confidence interval (CI), 61.1\u201390.4] at 67.0% (95% CI, 60.3\u201373.8) specificity. Next, the validated qMSP was applied to an independent series of hrHPV-positive cervical scrapes of 22 women with cervical cancer, 29 with advanced CIN2\/3 [i.e., women with a known preceding hrHPV infection (PHI) lasting \u22655 years as proxy of longer duration of lesion existence], and 19 with early CIN2\/3 (i.e., PHI &amp;lt;5 years). All carcinomas (22\/22) and advanced CIN2\/3 lesions (29\/29) were FAM19A4 methylation\u2013positive, compared with 42.1% (8\/19; 95% CI, 19.9\u201364.3) of early CIN2\/3 lesions. In conclusion, FAM19A4 is an attractive triage marker for hrHPV-positive women, with a high reassurance for the detection of cervical carcinoma and advanced CIN2\/3 lesions. Cancer Prev Res; 7(12); 1251\u20137. \u00a92014 AACR.<\/jats:p>","DOI":"10.1158\/1940-6207.capr-14-0237","type":"journal-article","created":{"date-parts":[[2014,10,4]],"date-time":"2014-10-04T01:36:28Z","timestamp":1412386588000},"page":"1251-1257","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["Methylation Analysis of the\n                    <i>FAM19A4<\/i>\n                    Gene in Cervical Scrapes Is Highly Efficient in Detecting Cervical Carcinomas and Advanced CIN2\/3 Lesions"],"prefix":"10.1158","volume":"7","author":[{"given":"Lise M.A.","family":"De Strooper","sequence":"first","affiliation":[{"name":"1Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.L.M.","family":"Meijer","sequence":"additional","affiliation":[{"name":"1Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Berkhof","sequence":"additional","affiliation":[{"name":"2Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albertus T.","family":"Hesselink","sequence":"additional","affiliation":[{"name":"1Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.F.","family":"Snijders","sequence":"additional","affiliation":[{"name":"1Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renske D.M.","family":"Steenbergen","sequence":"additional","affiliation":[{"name":"1Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle A.M.","family":"Heideman","sequence":"additional","affiliation":[{"name":"1Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2014,12,1]]},"reference":[{"key":"2022060816224478600_bib1","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/jnci\/92.9.690","article-title":"Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis","volume":"92","author":"Zur Hausen","year":"2000","journal-title":"J Natl cancer Inst"},{"key":"2022060816224478600_bib2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.1866","article-title":"HPV-mediated cervical carcinogenesis: concepts and clinical implications","volume":"208","author":"Snijders","year":"2006","journal-title":"J Pathol"},{"key":"2022060816224478600_bib3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrc3728","article-title":"Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions","volume":"14","author":"Steenbergen","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"2022060816224478600_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1868-7083-4-13","article-title":"Epigenetics alterations in preneoplastic and neoplastic lesions of the cervix","volume":"4","author":"Saavedra","year":"2012","journal-title":"Clin Epigenetics"},{"key":"2022060816224478600_bib5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/jnci\/djh031","article-title":"TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia","volume":"96","author":"Steenbergen","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"2022060816224478600_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1476-4598-9-167","article-title":"Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer","volume":"9","author":"Wilting","year":"2010","journal-title":"Mol Cancer"},{"key":"2022060816224478600_bib7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/path.2367","article-title":"Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC","volume":"1","author":"Overmeer","year":"2008","journal-title":"J Pathol"},{"key":"2022060816224478600_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/path.2598","article-title":"Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis","volume":"219","author":"Overmeer","year":"2009","journal-title":"J Pathol"},{"key":"2022060816224478600_bib9","doi-asserted-by":"crossref","first-page":"519619","DOI":"10.1155\/2013\/519619","article-title":"Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer","volume":"2013","author":"Tornesello","year":"2013","journal-title":"Biomed Res Int"},{"key":"2022060816224478600_bib10","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/ijc.28723","article-title":"Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy","volume":"135","author":"Hesselink","year":"2014","journal-title":"Int J Cancer"},{"key":"2022060816224478600_bib11","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1158\/1078-0432.CCR-10-2548","article-title":"Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women","volume":"17","author":"Hesselink","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2022060816224478600_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1470-2045(14)70019-1","article-title":"Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial","volume":"15","author":"Verhoef","year":"2014","journal-title":"Lancet Oncol"},{"key":"2022060816224478600_bib13","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/ijc.26326","article-title":"A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients","volume":"130","author":"Eijsink","year":"2012","journal-title":"Int J Cancer"},{"key":"2022060816224478600_bib14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/IGC.0b013e3181c7fe6e","article-title":"Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer","volume":"20","author":"Huang","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"2022060816224478600_bib15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ygyno.2010.10.029","article-title":"Detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages, a feasibility study","volume":"120","author":"Eijsink","year":"2011","journal-title":"Gynecol Oncol"},{"key":"2022060816224478600_bib16","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/ijc.28138","article-title":"CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease","volume":"133","author":"Bierkens","year":"2013","journal-title":"Int J Cancer"},{"key":"2022060816224478600_bib17","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1158\/1055-9965.EPI-14-0347","article-title":"Combined CADM1\/MAL methylation and cytology testing for colposcopy triage of high-risk HPV-positive women","volume":"23","author":"De Strooper","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060816224478600_bib18","doi-asserted-by":"crossref","first-page":"e91905","DOI":"10.1371\/journal.pone.0091905","article-title":"A promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive women","volume":"9","author":"Hansel","year":"2014","journal-title":"PLoS One"},{"key":"2022060816224478600_bib19","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/ijc.28790","article-title":"A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes","volume":"135","author":"Brentnall","year":"2014","journal-title":"Int J Cancer"},{"key":"2022060816224478600_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/path.4210","article-title":"Methylation-specific digital karyotyping of HPV16E6E7 expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis","volume":"231","author":"Steenbergen","year":"2013","journal-title":"J Pathol"},{"key":"2022060816224478600_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/jlb.59.1.61","article-title":"The role of MIP-1\u03b1 and hematopoiesis","volume":"59","author":"Cook","year":"1996","journal-title":"J Leucoc Biol"},{"key":"2022060816224478600_bib22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ijc.20076","article-title":"POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women","volume":"110","author":"Bulkmans","year":"2004","journal-title":"Int J Cancer"},{"key":"2022060816224478600_bib23","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet"},{"key":"2022060816224478600_bib24","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1128\/JCM.02078-05","article-title":"Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+\/6+ PCR method in a population-based cervical screening program","volume":"44","author":"Hesselink","year":"2006","journal-title":"J Clin Microbiol"},{"key":"2022060816224478600_bib25","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jcp.2003.011841","article-title":"The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996","volume":"57","author":"Bulk","year":"2004","journal-title":"J Clin Pathol"},{"key":"2022060816224478600_bib26"},{"key":"2022060816224478600_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/aje\/kwp390","article-title":"Impact of improved classification on the association of human papillomavirus with cervical precancer","volume":"171","author":"Castle","year":"2010","journal-title":"Am J Epidemiol"},{"key":"2022060816224478600_bib28","doi-asserted-by":"crossref","first-page":"E579","DOI":"10.1002\/ijc.26496","article-title":"Chromosomal profiles of high-grade cervical intraepithelial neoplasia relate to duration of preceding high-risk human papillomavirus infection","volume":"131","author":"Bierkens","year":"2012","journal-title":"Int J Cancer"},{"key":"2022060816224478600_bib29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/1471-2407-12-551","article-title":"Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape","volume":"12","author":"Snellenberg","year":"2012","journal-title":"BMC Cancer"},{"key":"2022060816224478600_bib30","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/IGC.0000000000000155","article-title":"PAX1 methylation as a potential biomarker for cervical cancer screening","volume":"24","author":"Kan","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"2022060816224478600_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2014.08.012","article-title":"Methylated ZNF582 gene as a marker for triage of women with Pap smear reporting low-grade squamous intraepithelial lesions - A Taiwanese Gynecologic Oncology Group (TGOG) study","author":"Lin","year":"2014  16","journal-title":"Gynecol Oncol"},{"key":"2022060816224478600_bib32","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ijc.22167","article-title":"Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands","volume":"120","author":"Rebolj","year":"2007","journal-title":"Int J Cancer"},{"key":"2022060816224478600_bib33","doi-asserted-by":"crossref","first-page":"c1040","DOI":"10.1136\/bmj.c1040","article-title":"HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study","volume":"340","author":"G\u00f6k","year":"2010","journal-title":"BMJ"},{"key":"2022060816224478600_bib34","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.ejca.2011.11.022","article-title":"Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme: characteristics of the responders","volume":"48","author":"G\u00f6k","year":"2012","journal-title":"Eur J Cancer"},{"key":"2022060816224478600_bib35","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0140-6736(11)61522-5","article-title":"Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial","volume":"378","author":"Lazcano-Ponce","year":"2011","journal-title":"Lancet"},{"key":"2022060816224478600_bib36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/sj.bjc.6606040","article-title":"The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600)","volume":"104","author":"Giorgi Rossi","year":"2011","journal-title":"Br J Cancer"},{"key":"2022060816224478600_bib37","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/ijc.27790","article-title":"High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening","volume":"132","author":"Snijders","year":"2013","journal-title":"Int J Cancer"},{"key":"2022060816224478600_bib38","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/bjc.2011.277","article-title":"Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer","volume":"105","author":"Gyllensten","year":"2011","journal-title":"Br J Cancer"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/7\/12\/1251\/2252864\/1251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/7\/12\/1251\/2252864\/1251.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T14:27:19Z","timestamp":1654698439000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/7\/12\/1251\/50246\/Methylation-Analysis-of-the-FAM19A4-Gene-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,1]]},"published-print":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-14-0237","relation":{},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,1]]}}}